Join
Live feed
·
PRReleasevia Quantisnow
Indaptus Therapeutics Inc. logo

Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit

ByQuantisnow·Wall Street's wire, on your screen.
INDP· Indaptus Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INDP (Indaptus Therapeutics Inc.) and more on Quantisnow.